Literature DB >> 10215850

Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization.

A Miranda-Vizuete1, A E Damdimopoulos, J R Pedrajas, J A Gustafsson, G Spyrou.   

Abstract

We have isolated a 1918-bp cDNA from a human adrenal cDNA library which encodes a novel thioredoxin reductase (TrxR2) of 521 amino acid residues with a calculated molecular mass of 56.2 kDa. It is highly homologous to the previously described cytosolic enzyme (TrxR1), including the conserved active site CVNVGC and the FAD-binding and NADPH-binding domains. However, human TrxR2 differs from human TrxR1 by the presence of a 33-amino acid extension at the N-terminus which has properties characteristic of a mitochondrial translocation signal. Northern-blot analysis identified one mRNA species of 2.2 kb with highest expression in prostate, testis and liver. We expressed human TrxR2 as a fusion protein with green fluorescent protein and showed that in vivo it is localized in mitochondria. Removal of the mitochondrial targeting sequence abolishes the mitochondrial translocation. Finally, we determined the genomic organization of the human TrxR2 gene, which consists of 18 exons spanning about 67 kb, and its chromosomal localization at position 22q11.2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215850     DOI: 10.1046/j.1432-1327.1999.00286.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  27 in total

Review 1.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Mitochondrial thioredoxin in regulation of oxidant-induced cell death.

Authors:  Yan Chen; Jiyang Cai; Dean P Jones
Journal:  FEBS Lett       Date:  2006-11-14       Impact factor: 4.124

3.  Identification and characterization of a mitochondrial thioredoxin system in plants.

Authors:  C Laloi; N Rayapuram; Y Chartier; J M Grienenberger; G Bonnard; Y Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence.

Authors:  L Zhong; E S Arnér; A Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 5.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

6.  The rare TXNRD1_v3 ("v3") splice variant of human thioredoxin reductase 1 protein is targeted to membrane rafts by N-acylation and induces filopodia independently of its redox active site integrity.

Authors:  Marcus Cebula; Naazneen Moolla; Alexio Capovilla; Elias S J Arnér
Journal:  J Biol Chem       Date:  2013-02-14       Impact factor: 5.157

7.  Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems.

Authors:  Q A Sun; L Kirnarsky; S Sherman; V N Gladyshev
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

8.  Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide.

Authors:  Christopher Horst Lillig; Maria Elisabet Lönn; Mari Enoksson; Aristi Potamitou Fernandes; Arne Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-24       Impact factor: 11.205

9.  Cloning of thioredoxin h reductase and characterization of the thioredoxin reductase-thioredoxin h system from wheat.

Authors:  Antonio J Serrato; Juan M Pérez-Ruiz; Francisco J Cejudo
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

10.  Platyhelminth mitochondrial and cytosolic redox homeostasis is controlled by a single thioredoxin glutathione reductase and dependent on selenium and glutathione.

Authors:  Mariana Bonilla; Ana Denicola; Sergey V Novoselov; Anton A Turanov; Anna Protasio; Darwin Izmendi; Vadim N Gladyshev; Gustavo Salinas
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.